Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
- Triggering Signals of BRCA1 Breast Cancer (K Kessenbrock)
- Testing Diverse Groups Finds New Breast Cancer Genes (L Teras)
- Black Women & Genetic Testing (J Palmer)
- Women 65+ & Genetic Tests for Breast Cancer Risk (L Teras)
- High-Risk Genes and Screening (A Patel)
- New Risk Calculation May Affect Breast Cancer Screening (L Teras)
- Black Men and Breast Cancer (H Sung)
- Platelets May Help Breast Cancer Spread (E Battinelli)
- Natural Killer Cells & TNBC (R. Chakrabarti)
- Improving Chemotherapy (O Sahin)
- Combo Treatment for TNBC (K Varley)
- Treatments Attack Cell Division (A Holland)
- ER+ Treatment in Mice (P Kenny)
- Blood DNA Monitors Metastasis Treatment (H P Ji)
- PTK6 Gene as Treatment Target (H Irie)
- Time-Lapse Cell Movies (S Spencer)
- 3D Mini Breast Tumors May Help ID New Cancer Treatments
- AI Tool Improves Breast Cancer Prognosis Accuracy
- Exercise & Sitting Time (E. Rees-Punia)
- Cancer Risk Factors in LGBTQ Populations (B. Charlton)
- CPS-3 Disparities Studies
- Cancer Disparities in the US (F. Islami)
- Housing Assistance and Mammograms (H Lee)
- Clinical Trial Treatment Cost App (L Hamel)
- Podcasts, TheoryLab
- Patients Health Insurance Tool (M. Politi)
- Breast Cancer Treatment in Ethiopia (A. Jemal)
- Better Survival Requires Better Insurance (J Zhao)
- Medicaid Eligibility Limits (J Zhao)
- New Treatment for Neuroblastoma (A Heczey)
- Oncogenic Fusions AML (S Meshinchi)
- Genetic Risks (L Teras)
- New Medulloblastoma Drugs (J Rodriguez-Blanco)
- Potential New Hope for MLL (J Grembecka)
- Increase in Brain Tumor Diagnosis (K Miller)
- Longer Life Expectancy for Survivors (J Yeh)
- Potential Target for New Osteosarcoma Drugs (C Benavente)
- At-Home Chemo for Children with HR ALL (L Ranney)
- Childhood Cancer Research Landscape Report
- Tumor-Infiltrating Neutrophils (R. Sumagin)
- New Epigenetic Target (K Rai)
- Extra Chromosomes (Aneuploidy) Effect on Cancer (J. Sheltzer)
- Discovery of a New Biomarker Is the First Step to New Treatment (C. Maher)
- Designer Virus Targets and Kills CRC Cells in Mice (S. Warner)
- Tiny Sensor in Mice May Find Cancer That's Trying to Spread (L. Hao)
- Targeting a Protein “Turned on” by Mistake (N. Gao)
- Spatial Map Intestines (J Hickey)
- CRC Treatment Podcasts
- Keto Molecule & Colorectal Cancer (M Levy)
- Availability of Healthy Food (L Tussing-Humphreys)
- 45 Min/Day of Physical Activity (A Minihan)
- Fewer than 10K Steps/Day (A Patel)
- Yogurt & Cheese & ER- Breast Cancer (M McCullough)
- Stage 2 Clinical Trials for New Endometrial Cancer Drug (V Bae-Jump)
- Hard-to-Starve Pancreatic Cancer Cells (N Kalaany)
- Coffee Risks for Colorectal Cancer (C Um)
- Food Parasite & Brain Cancer Risk (J Hodge)
- Exercise & Quality of Life in Older Survivors (E Rees-Punia)
- 21 Metabolites Linked with Breast Cancer (Y Wang)
- Replacing Sitting May Affect Weight (E Rees-Punia)
- CPS-3 Researchers Ask What People Eat and Check Urine Samples (Y Wang)
- Video Games Motivate Exercise? (E. Lyons)
- Food Choices and Colon Cancer Risk (P. Chandler)
- Race, Exercise & Breast Cancer (C. Dallal)
- Diet with Colorectal Cancer (M. Guinter)
- Biomarkers May Improve Prediction (Y Wang)
- Kickstart NSCLCs Clinical Trials (L. Eichner)
- Mapping Mitochondria's “Dance” (D. Shackleford)
- E-Cig Use Ages 18 to 29 (P. Bandi)
- Stopping Smoking Earlier in Life (F Islami)
- Most with Lung Cancer Smoked (A Jemal)
- Furthering Lung Cancer Screening & Equity (S Fedewa)
- Mouse Lung Organoids for Research (C Kim)
- Quality of Life for Lung Cancer Survivors (J Temel)
- Precision Therapies for NSCLC (P Jänne)
- Cancer Deaths from Smoking (F Islami)
- Lung Cancer Surgery Disparities (A Jemal)
- BRG1-Deficient Lung Cancers (C Kim)
- Yoga for Couples with Lung Cancer (K Milbury)
- Metabolic Differences as New Drug Targets (A Marcus)
- CPS-II & CPS-3 Inform About Risks of Ovarian Cancer
- Machine Learning & Glowing Nanosensors (D Heller)
- Ovarian Cancer May Start in Fallopian Tube Cells (K Lawrenson)
- New Gene Linked with Deadliest Type (C Han)
- Gene-Testing Tools May Personalize Care (A Sood)
- Chromosome-Hoarding Ovarian Cancer Cells & Treatment (J Sheltzer)
- Nanoparticles as Drug Delivery for Metastases (X Lu)
- Turning Off 2 Proteins to Slow HGSC (P Kreeger)
- Targeted Light Therapy in Mice (M Bai)
- Nanoparticles, CAR T, and CRISPR (M Stephan)
- Endometriosis & Ovarian Cancer in Mice (M Wilson)
- Ovarian Cancer Special Section
- UV Exposure, Melanoma, & Dark Skin Types (A. Adamson)
- Melanoma and Lipid Droplets (R. White)
- Zebrafish and Acral Melanoma (R. White)
- T-Cell Lymphoma and PD1 (J. Choi)
- New Drug Destroys Cancer-Causing Protein (C. Crews)
- Virus & Merkel Cell Skin Cancer (R. Wang)
- Non-Genetic Drug Resistance (S. Spencer)
- Hijacking the Body's Sugar (R. Wang)
- Telling about High Risk (P. Kanetsky)
- Brain Metastasis and Alzheimer’s (E. Hernando)
- Exhausted Melanoma "Killer" Cells (W. Cui)
New News About Breast Cancer Survivors' Risk of New Cancers
Data from breast cancer survivors showed that the cancer’s subtype and age at diagnosis affect the risk for developing a new type of cancer.
The Challenge
Invasive breast cancer is the most commonly diagnosed cancer among women in the United States. In 2019, there were more than 3.9 million survivors of breast cancer in the US. With improvements in the treatment for breast cancer and the increase in the US aging population, the number of breast cancer survivors is expected to increase. Plus, most of those survivors live for many years after their diagnosis. So, it’s more important than ever to take steps to keep improving quality of life after diagnosis and treatment of breast cancer.
One issue affecting breast cancer survivors is the risk of developing a new type of cancer (called a subsequent primary cancer or second cancer). Compared to the general population, breast cancer survivors have a 17% higher risk of developing a new cancer.
However, this increased risk is not the same for all breast cancer survivors. Studies have shown that the level of risk for developing a new type of cancer depends on the:
- Age at diagnosis of the first breast cancer
- Treatments received: radiotherapy, chemotherapy, and/or hormonal therapy
- Lifestyle factors, such as using tobacco and having obesity
- Genetic susceptibility
- Subtype of breast cancer that was diagnosed
How these factors interact and contribute to risk of developing a specific type of subsequent primary cancer is not well understood and needs more study.
The Research
A group of researchers from the American Cancer Society (ACS), Dana-Farber Cancer Institute, Mayo Clinic, and Institute for Health & Equity at the Medical College of Wisconsin, recently published their findings after studying the risk of 26 subsequent primary cancers among female breast cancer survivors based on their age when first diagnosed and the cancer’s hormone receptor status.
Most women live decades after being diagnosed with breast cancer, but some women may develop a new primary cancer years after successful treatment. Currently, there’s limited knowledge about the factors associated with a higher or lower risk for new primary cancers specific to breast cancer survivors, and there’s no established tool that predicts an individual’s risk of developing a new cancer. In this study, we found that the risk of developing a new primary cancer varies by the subtype of breast cancer a woman has as well as the age she was when she was first diagnosed with breast cancer. This result both highlights the need for tailored recommendations for preventing and screening for new primary cancers in breast cancer survivors based on their specific, personal risks and provides information to help establish such guidelines.
Hyuna Sung, PhD
American Cancer Society
Surveillance & Health Equity Science
Their study, led by ACS researcher Hyuna Sung, PhD, looked at data for women who were first diagnosed with invasive breast cancer between 1992 and 2015 and who survived for a year or longer. This included 431,222 women ages 20 to 84 years.
To evaluate women’s risks, they compared the risk of developing subsequent primary cancers among survivors versus the risk expected in the general population of the same age and race.
Most common subsequent cancers. Sung and her colleagues found that regardless of a woman’s breast cancer hormone receptor status, survivors were more likely than the general population to be diagnosed with 7 types of cancers:
- Acute nonlymphocytic leukemia (ANLL)
- Breast cancer (This is a second breast cancer—different from the first cancer coming back.)
- Colon cancer
- Endometrial Cancer
- Lung cancer
- Oral cavity/pharynx cancer
- Sarcoma
How hormone status and age affect risk. The researchers found that compared to the general public, breast cancer survivors had a greater risk of developing a subsequent primary cancer when their breast cancer had been:
- HR-negative (44% higher risk) than those with an HR-positive cancer (20% higher risk). Those with HR-negative cancers were more likely to develop ANLL and cancers of the peritoneum, breast, ovary, and lung.
- Diagnosed when they were between 20 and 49 years of age (70% higher risk for HR-positive and 124% higher risk for HR-negative) than for those diagnosed between the ages of 50 to 84 (11% higher risk for HR-positive and 22% higher risk for HR-negative)
Subsequent primary breast cancers. 1 in 20 survivors developed a new primary breast cancer, with 70% occurring in the other breast (contralateral).
Cancer types linked with specific risks:
- Only women with a history of an HR-positive breast cancer had higher risks for cancers of the thyroid, small intestine, pancreas, and bladder and melanoma. Risks varied based on the woman’s age at diagnosis.
- Only women with a history of an HR-negative breast cancer had higher risks for cancers in the esophagus, ovary, and peritoneum. Risks varied based on the woman’s age at diagnosis. For instance, women with HR-negative breast cancer also had a higher risk for ovarian cancer when their cancer was diagnosed before age 40.
Why It Matters
These findings suggest that the risk of breast cancer survivors developing a subsequent primary cancer differs greatly based on the initial HR subtype and a woman’s age at diagnosis. That knowledge can be used to develop survivorship care plans with more targeted approaches for cancer prevention and early detection, which can help ease the burden of new cancers among breast cancer survivors.